» Articles » PMID: 9503879

Modeling Two-state Disease Processes with Random Effects

Overview
Publisher Springer
Date 1997 Jan 1
PMID 9503879
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Many chronic medical conditions are manifested by alternating sojourns in symptom-free and symptomatic states. In many cases, in addition to their relapsing and remitting nature, these conditions lead to worsening disease patterns over time and may exhibit seasonal trends. We develop a mixed-effect two-state model for such disease processes in which covariate effects are modeled multiplicatively on transition intensities. The transition intensities, in turn, are functions of three time scales: the semi-Markov scale involving the backward recurrence time for the cyclical component, the Markov scale for the time trend component, and a seasonal time scale. Multiplicative bivariate log-normal random effects are introduced to accommodate heterogeneity in disease activity between subjects and to admit a possible negative correlation between the transition intensities. Maximum likelihood estimation is carried out using Gauss-Hermite integration and a standard Newton-Raphson procedure. Tests of homogeneity are presented based on score statistics. An application of the methodology to data from a multi-center clinical trial of chronic bronchitis is provided for illustrative purposes.

Citing Articles

Investigating the Coronavirus Disease 2019 Process and its Related Occurrences during the Treatment Course.

Nejatollahi S, Kazempour Dizaji M, Zare A, Abedini A, Varahram M, Kiani A Tanaffos. 2024; 22(3):332-336.

PMID: 38638390 PMC: 11022195.


Bayesian approach to investigate a two-state mixed model of COPD exacerbations.

Largajolli A, Beerahee M, Yang S J Pharmacokinet Pharmacodyn. 2019; 46(4):371-384.

PMID: 31197640 PMC: 6848253. DOI: 10.1007/s10928-019-09643-6.


Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review.

Olariu E, Cadwell K, Hancock E, Trueman D, Chevrou-Severac H Clinicoecon Outcomes Res. 2017; 9:537-546.

PMID: 28979151 PMC: 5589111. DOI: 10.2147/CEOR.S135445.


The role of mathematical modeling in medical research: "research without patients?".

Chambers R Ochsner J. 2011; 2(4):218-23.

PMID: 21765699 PMC: 3117507.


Analysis of Smoking Cessation Patterns Using a Stochastic Mixed-Effects Model With a Latent Cured State.

Luo S, Crainiceanu C, Louis T, Chatterjee N J Am Stat Assoc. 2009; 103(483):1002-1013.

PMID: 19305513 PMC: 2658598. DOI: 10.1198/016214507000001030.


References
1.
Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N . Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc. 1995; 41(1):1-4. DOI: 10.1016/s0016-5107(95)70266-0. View

2.
Fietta A, MERLINI C, Uccelli M, Gialdroni Grassi G, Grassi C . Immunological and clinical effect of long-term oral treatment with RU 41740 in patients with chronic bronchitis: double-blind trial long-term versus standard dose regimen. Respiration. 1992; 59(5):253-8. DOI: 10.1159/000196069. View

3.
Crouchley R, Pickles A . A specification test for univariate and multivariate proportional hazards models. Biometrics. 1993; 49(4):1067-76. View

4.
Xue X, Brookmeyer R . Bivariate frailty model for the analysis of multivariate survival time. Lifetime Data Anal. 1996; 2(3):277-89. DOI: 10.1007/BF00128978. View

5.
Commenges D, Andersen P . Score test of homogeneity for survival data. Lifetime Data Anal. 1995; 1(2):145-56; discussion 157-9. DOI: 10.1007/BF00985764. View